BLACK SWAN PHARMACEUTICALS
Black Swan Pharmaceuticals is dedicated to discovering and progressing innovative gene-targeting therapeutics for neurological disorders. It was incorporated in 2018, is the realization of an initiative, led by Prof Anthony Akkari in partnership with the Perron Institute to accelerate the ground-breaking research occurring at its Motor Neurone Research Laboratory and other research institutes in Western Australia. The BSP business model will efficiently and economically progress these assets from the discovery setting to US FDA Investigational New Drug Application (IND) submission readiness divestiture for initiation of clinical development.
BLACK SWAN PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2018-01-01
Address:
Wake Forest, North Carolina, United States
Country:
United States
Website Url:
http://www.blackswan-pharma.com
Total Employee:
1+
Status:
Active
Contact:
+44 20 8677 4533
Total Funding:
130.24 K USD
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Current Employees Featured
Founder
Official Site Inspections
http://www.blackswan-pharma.com
- Host name: 34.70.167.72.host.secureserver.net
- IP address: 72.167.70.34
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Black Swan Pharmaceuticals"
Black Swan Pharmaceuticals - Crunchbase Company Profile
Black Swan Pharmaceuticals is dedicated to discovering and progressing innovative gene-targeting therapeutics for neurological disorders. It was incorporated in 2018, is the realization …See details»
Black Swan Pharmaceuticals (BSP) | LinkedIn
Black Swan Pharmaceuticals (BSP) Biotechnology Research Wake Forest, NC 137 followers Using its unique RNA based platform to develop antisense therapies for the treatment of ALS and PDSee details»
Black Swan Pharmaceuticals | Pharmaceutical and …
Black Swan Pharmaceutical Ltd is an indigenous pharmaceutical company involved in all aspect of the pharmaceutical and medical industry. At Black Swan Pharmaceuticals, we believe that all Nigerians deserve access to innovative …See details»
About Us - BLACK SWAN PHARMA
We aim at bringing affordable healthcare to the good people of Nigeria and the developing world particularly those in West Africa, not only directly but also indirectly by working with various …See details»
Black Swan Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Blackswan-pharma.com. Startups | Private Company | 2018 | North Carolina, United States | < 10 | blackswan-pharma.com. Last update 08 Mar 2025. Overview. Pipeline. Deal. ... The statistics …See details»
Black Swan Pharmaceuticals Inc. | North Carolina Biotech Center
Black Swan Pharmaceuticals is developing preclinical gene targeting therapeutics for motor neurone disease (MND) / Amyotrophic Lateral Sclerosis (ALS) and other neurological disorders.See details»
BlackSwan Pharma GmbH, Leipzig - North Data
Wortmarke: »BlackSwan Pharma« 05.02.2009 Eintragung · Geschäftsführer: Wolfgang Tiedke · Anschrift · Kapital: 25.000 € · Gesellschaftsvertrag · UnternehmensgegenstandSee details»
Black Swan Pharmaceuticals (BSP) Overview | Salary.com
Discover essential details about Black Swan Pharmaceuticals (BSP), including address, contact, and journey of our company's evolution.See details»
Products - BLACK SWAN PHARMA
We at Black Swan Pharmaceuticals are committed to bringing affordable generic drugs closer to patients that needs them the most by sourcing the best available price without compromising …See details»
Black Swan Pharmaceuticals - PitchBook
May 1, 2019 www.blackswan-pharma.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 9008 Laura Lake Drive; Wake …See details»
Partnership established to expedite MND treatment
Mar 19, 2020 Partnership established to expedite MND treatment. Accelerating the conversion of laboratory research findings into clinical trials is the focus of a new partnership between the Perron Institute in Western Australia and United …See details»
Black Swan Pharmaceuticals - VentureRadar
"Black Swan Pharmaceuticals (BSP) is dedicated to discovering innovative gene targeting therapeutics for Amyotrophic Lateral Sclerosis (ALS) and other neurological disorders.See details»
Black Swan biopharmaceutical
B lackswan B iopharma (WA) is a leading innovator and the first biopharmaceutical in conducting advanced technological research and application of the Australian sandalwood (santalum …See details»
Strategic Cooperation with Nanospectra and BlackSwan ... - Grand …
(December 9, 2020, Hong Kong) China Grand Pharmaceutical and Healthcare Holdings Limited (“GP (HK)” or the “Company”, together with its subsidiaries, the “Group”, stock code: 00512) is …See details»
China Billionaire’s Grand Pharma Buys BlackSwan Vascular For
Apr 24, 2023 Grand Pharmaceutical Group, a China pharmaceuticals supplier whose biggest shareholder is billionaire Hu Kaijun, has agreed to buy 87.5% of U.S.-based vascular drug …See details»
BLACKSWAN PHARMA PRIVATE LIMITED - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for BLACKSWAN PHARMA PRIVATE LIMITED of Hyderabad, Telangana. Get the latest business insights from …See details»
Broad Pharma acquired BlackSwan to deepen the pipeline layout …
Apr 27, 2023 The original shareholders acquired 87.5 per cent of the company. Upon completion of the transaction, BlackSwan will become a wholly owned subsidiary of Broad …See details»
Team - BLACKSWAN Foundation
She has been following for many years yet the activities of the BLACKSWAN Foundation where, from 2012 to 2018, she had the role of Project Coordinator. ... Karima Soudani graduated from …See details»
Black Swan Pharmaceuticals - Products, Competitors, Financials ...
Headquarters Location. 9008 Laura Lake Drive . Wake Forest, North Carolina, 27587, United States +44 208 677 4533See details»
远大医药收购BlackSwan，深化肿瘤介入创新产品管线 - 雪球
4月23日， 远大医药 发布新闻稿称，已于近日签订股权收购协议，以不超过3750万美元从BlackSwan Vascular原股东收购该公司的87.5%股权。待交易完成后，BlackSwan公司将会成为 …See details»